BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28601657)

  • 1. Significance of positive and inhibitory regulators in the TGF-β signaling pathway in colorectal cancers.
    Coates RF; Gardner JA; Gao Y; Cortright VM; Mitchell JM; Ashikaga T; Skelly J; Yang MX
    Hum Pathol; 2017 Aug; 66():34-39. PubMed ID: 28601657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma.
    Fan J; Yang MX; Ouyang Q; Fu D; Xu Z; Liu X; Mino-Kenudson M; Geng J; Tang F
    Hum Pathol; 2016 Sep; 55():151-8. PubMed ID: 27195906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Canonical TGF-β Signaling in Urothelial Bladder Cancer.
    Stojnev S; Krstić M; Čukuranović Kokoris J; Conić I; Petković I; Ilić S; Milosević-Stevanović J; Veličković LJ
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31238579
    [No Abstract]   [Full Text] [Related]  

  • 4. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
    Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
    J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
    Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
    Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
    Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-β/Smad signaling pathway.
    Geng J; Fan J; Ouyang Q; Zhang X; Zhang X; Yu J; Xu Z; Li Q; Yao X; Liu X; Zheng J
    Oncotarget; 2014 Jul; 5(14):5700-11. PubMed ID: 25026293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.
    Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ
    Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
    Singhi AD; Foxwell TJ; Nason K; Cressman KL; McGrath KM; Sun W; Bahary N; Zeh HJ; Levy RM; Luketich JD; Davison JM
    Am J Surg Pathol; 2015 Apr; 39(4):487-95. PubMed ID: 25634752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of stromal GREM1 expression in colorectal cancer.
    Jang BG; Kim HS; Chang WY; Bae JM; Oh HJ; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
    Hum Pathol; 2017 Apr; 62():56-65. PubMed ID: 28041973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMAD4/DPC4 expression and prognosis in human colorectal cancer.
    Isaksson-Mettävainio M; Palmqvist R; Forssell J; Stenling R; Oberg A
    Anticancer Res; 2006; 26(1B):507-10. PubMed ID: 16739311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer.
    Gulubova M; Manolova I; Ananiev J; Julianov A; Yovchev Y; Peeva K
    Int J Colorectal Dis; 2010 May; 25(5):591-9. PubMed ID: 20165854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumoral epithelial and stromal expression of SMAD proteins in pancreatic ductal adenocarcinomas.
    Handra-Luca A; Hammel P; Sauvanet A; Ruszniewski P; Couvelard A
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):294-302. PubMed ID: 22581056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.
    Fleming NI; Jorissen RN; Mouradov D; Christie M; Sakthianandeswaren A; Palmieri M; Day F; Li S; Tsui C; Lipton L; Desai J; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Zhu HJ; Mariadason JM; Burgess AW; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
    Cancer Res; 2013 Jan; 73(2):725-35. PubMed ID: 23139211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
    Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
    Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer.
    Togo N; Ohwada S; Sakurai S; Toya H; Sakamoto I; Yamada T; Nakano T; Muroya K; Takeyoshi I; Nakajima T; Sekiya T; Yamazumi Y; Nakamura T; Akiyama T
    World J Gastroenterol; 2008 Aug; 14(31):4880-8. PubMed ID: 18756595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway.
    Bae JM; Kim JH; Rhee YY; Cho NY; Kim TY; Kang GH
    World J Gastroenterol; 2015 Sep; 21(33):9749-57. PubMed ID: 26361422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers.
    Chun HK; Jung KU; Choi YL; Hong HK; Kim SH; Yun SH; Kim HC; Lee WY; Cho YB
    Oncology; 2014; 86(3):159-69. PubMed ID: 24643220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.